The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of beta-amyloid (Q81348622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of beta-amyloid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Cristiano Chiamulera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Vittorina Della-Bianca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Elena Formaggio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alessio Montresor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Filippo Rossi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

11 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

126-134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

The toxicity in vitro of beta-amyloid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Alzheimer's disease is a synaptic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Spontaneous Aggregation and Cytotoxicity of the β-Amyloid Aβ1–40: A Kinetic Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Observation of metastable Abeta amyloid protofibrils by atomic force microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Oligomerizaiton and fibril asssembly of the amyloid-beta protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Diversity in the mechanisms of neuronal cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.09.004

10.1016/J.YEXCR.2005.09.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16223482%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference